Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Medicine
|
January 25, 2025
Long-Term Lung Sequelae in Survivors of Severe/Critical COVID-19 Pneumonia: The "Non-Steroid", "Non-Interventional" Approach
Elvira-Markela Antonogiannaki, Ioannis Grigoropoulos, Effrosyni D Manali, et al.
ERJ Open Research
|
March 30, 2022
Autoimmune pulmonary alveolar proteinosis in children
Matthias Griese, Panagiota Panagiotou, Effrosyni D Manali, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
December 10, 2024
Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients
Ourania Kotsiou, Paraskevi Kirgou, Argyrios Tzouvelekis, et al.
International Archives of Allergy and Immunology
|
June 23, 2020
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis
Maria Kallieri, Eleftherios Zervas, Konstantinos Katsoulis, et al.
Advances in Respiratory Medicine
|
November 25, 2024
Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF Patients
Ioannis Tomos, Andriana I Papaioannou, Zoe I Daniil, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
April 13, 2026
Geographical variability in severe asthma: comparison of patients' characteristics between national, regional and international cohorts in ISAR
Maria Kallieri, Nikolaos G Papadopoulos, Eleftherios Zervas, et al.
ERJ Open Research
|
November 26, 2025
The phenotypic state of biallelic <i>SERPINA1 Q0</i> variants in α<sub>1</sub>-antitrypsin deficiency
Spyros A Papiris, Martina Veith, Ilaria Ferrarotti, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 12, 2023
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study
Maria Kallieri, Andriana I Papaioannou, Eleftherios Zervas, et al.
Allergy
|
May 20, 2022
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response
Maria Kallieri, Eleftherios Zervas, Evangelia Fouka, et al.
Allergy and Asthma Proceedings
|
December 31, 2024
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A <i>post-hoc</i> analysis of RELIght study
Andriana I Papaioannou, Maria Kallieri, Eleftherios Zervas, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Medicine
|
January 25, 2025
Long-Term Lung Sequelae in Survivors of Severe/Critical COVID-19 Pneumonia: The "Non-Steroid", "Non-Interventional" Approach
Elvira-Markela Antonogiannaki, Ioannis Grigoropoulos, Effrosyni D Manali, et al.
ERJ Open Research
|
March 30, 2022
Autoimmune pulmonary alveolar proteinosis in children
Matthias Griese, Panagiota Panagiotou, Effrosyni D Manali, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
December 10, 2024
Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients
Ourania Kotsiou, Paraskevi Kirgou, Argyrios Tzouvelekis, et al.
International Archives of Allergy and Immunology
|
June 23, 2020
Mepolizumab in Severe Eosinophilic Asthma: A 2-Year Follow-Up in Specialized Asthma Clinics in Greece: An Interim Analysis
Maria Kallieri, Eleftherios Zervas, Konstantinos Katsoulis, et al.
Advances in Respiratory Medicine
|
November 25, 2024
Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF Patients
Ioannis Tomos, Andriana I Papaioannou, Zoe I Daniil, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
April 13, 2026
Geographical variability in severe asthma: comparison of patients' characteristics between national, regional and international cohorts in ISAR
Maria Kallieri, Nikolaos G Papadopoulos, Eleftherios Zervas, et al.
ERJ Open Research
|
November 26, 2025
The phenotypic state of biallelic <i>SERPINA1 Q0</i> variants in α<sub>1</sub>-antitrypsin deficiency
Spyros A Papiris, Martina Veith, Ilaria Ferrarotti, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
December 12, 2023
Switching from omalizumab to mepolizumab in severe asthmatics: A post hoc analysis of the RELight study
Maria Kallieri, Andriana I Papaioannou, Eleftherios Zervas, et al.
Allergy
|
May 20, 2022
RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response
Maria Kallieri, Eleftherios Zervas, Evangelia Fouka, et al.
Allergy and Asthma Proceedings
|
December 31, 2024
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A <i>post-hoc</i> analysis of RELIght study
Andriana I Papaioannou, Maria Kallieri, Eleftherios Zervas, et al.
Page
of 4